PLUS THERAPEUTICS Common Stock Stock Performance
as on June 25, 2026 at 2:16 pm IST
Day's Low
Day's High
$3.90$4.15
1.52%
Downside
4.80%
Upside
52 Week's Low
52 Week's High
$2.90$23.4326.77%
Downside
491.54%
Upside
PLUS THERAPEUTICS Common Stock share price movements today
- Previous Close
- $4.08
- Open
- $4.12
- Volume
- 417.5K
- Day's Low - High
- $3.90 - $4.15
- 52 Week Low - High
- $2.90 - $23.43
PLUS THERAPEUTICS Common Stock Historical Returns
- 1 Month Return
- -39.91 %
- 3 Month Return
- -35.58 %
- 1 Year Return
- -49.71 %
- 3 Year Return
- -94.71 %
- 5 Year Return
- -99.62 %
PLUS THERAPEUTICS Common Stock Stock Fundamentals & Key Indicators
Check PLUS THERAPEUTICS Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$28.1M
EPS (TTM)
-3.9225
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0.19
Industry PE ratio
-3.750247191011236
PEG Ratio
2.4504
EBITDA
-18.5M
Revenue (TTM)
5.2M
Profit Margin
-230.24%
Return On Equity TTM
-522.50%
PLUS THERAPEUTICS Common Stock Stock Valuation
Track how PLUS THERAPEUTICS Common Stock P/E has moved over time to understand its valuation trends.
PLUS THERAPEUTICS Common Stock in the last 5 years
Lowest (-3.37x)
March 31, 2026
Industry (-3.75x)
June 25, 2026
Today (0.19x)
June 25, 2026
Highest (-0.43x)
December 31, 2023
Today’s Price to Earnings Ratio: 0.19x
PLUS THERAPEUTICS Common Stock vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of PLUS THERAPEUTICS Common Stock with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $28.1M | -99.62% | 0.19 | -230.24% | NA | |
| BUY | $38.5B | 67.66% | 72.41 | 12.55% | NA | |
| BUY | $118.9B | 144.52% | 27.78 | 35.51% | NA | |
| BUY | $64.8B | 13.24% | 15.08 | 29.65% | 0.58% |
Stock Returns calculator for PLUS THERAPEUTICS Common Stock Stock including INR - Dollar returns
The PLUS THERAPEUTICS Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
PLUS THERAPEUTICS Common Stock investment value today
Current value as on today
₹55,354
Returns
Returns from PLUS THERAPEUTICS Common Stock Stock
Dollar Impact
₹5,100 (+5.1%)
Analyst Recommendation on PLUS THERAPEUTICS Common Stock Stock
Based on 10 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for PLUS THERAPEUTICS Common Stock. Average target price of $36
PLUS THERAPEUTICS Common Stock Share Price Target
Get share price movements and forecasts by analysts on PLUS THERAPEUTICS Common Stock.
What analysts predicted
89%UPSIDE
Target Price
$36
Current Price
$3.96
Analyzed by
10 Analysts
Target
$36.00
PLUS THERAPEUTICS Common Stock target price $36, a slight upside of 89% compared to current price of $3.96. According to 10 analysts rating.
Indian Investors' Interest in PLUS THERAPEUTICS Common Stock Stock
Search interest for PLUS THERAPEUTICS Common Stock Stock has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
PLUS THERAPEUTICS Common Stock Quarterly Profit & Loss
All numbers in Millions USD
PLUS THERAPEUTICS Common Stock Annual Profit & Loss
All numbers in Millions USD
PLUS THERAPEUTICS Common Stock Quarterly Cash Flow
All numbers in Millions USD
PLUS THERAPEUTICS Common Stock Annual Cash Flow
All numbers in Millions USD
Insights on PLUS THERAPEUTICS Common Stock
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.8% return, outperforming this stock by 69.5%
- NO EFFECT
Against Peers
In the last 3 years, PLUS THERAPEUTICS, Inc. Common Stock has experienced a drawdown of -94.7%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 74.7%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 4 quarters, 5.15M → -6.94M (in $), with an average decrease of 78.9% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, PSTV stock has moved down by -39.9%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 1.39M → 1.02M (in $), with an average decrease of 13.5% per quarter
About PLUS THERAPEUTICS Common Stock
| Organisation | PLUS THERAPEUTICS Common Stock |
| Headquarters | 6420 LEVIT GREEN BOULEVARD, Houston, TX, United States, 77021 |
| Industry | Biotechnology |
| CEO | Dr. Marc H. Hedrick M.B.A., M.D. |
| E-voting on shares | Click here to vote |
Key Management of PLUS THERAPEUTICS Common Stock
Name | Title |
|---|---|
Mr. Andrew J. Sims CPA | VP & CFO |
Mr. Russ Havranek M.B.A., M.S. | Executive Vice President of Commercial and Corporate Strategy |
Dr. Eric J. Daniels M.B.A., M.D. | Chief Development Officer |
Ms. Desiree Smith | Corporate Controller |
Mr. Russell W. Bradley | President & GM of CNSide Diagnostics, LLC |
Dr. Marc H. Hedrick M.B.A., M.D. | President, CEO & Director |
FAQs
What is PLUS THERAPEUTICS Common Stock share price today?
PLUS THERAPEUTICS Common Stock share price today is $3.96 as on at the close of the market. PLUS THERAPEUTICS Common Stock share today touched a day high of $4.15 and a low of $3.9.
What is the 52 week high and 52 week low for PLUS THERAPEUTICS Common Stock share?
PLUS THERAPEUTICS Common Stock share touched a 52 week high of $23.43 on and a 52 week low of $2.9 on . PLUS THERAPEUTICS Common Stock stock price today i.e. is closed at $3.96,which is 83.09% down from its 52 week high and 36.55% up from its 52 week low.
What is PLUS THERAPEUTICS Common Stock's market capitalisation today?
PLUS THERAPEUTICS Common Stock market capitalisation is $0.00T as on .
How to invest in PLUS THERAPEUTICS Common Stock Stock (PSTV) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for PLUS THERAPEUTICS Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in PLUS THERAPEUTICS Common Stock Shares that will get you 0.3788 shares as per PLUS THERAPEUTICS Common Stock share price of $3.96 per share as on June 25, 2026 at 8:46 am IST.
What is the minimum amount required to buy PLUS THERAPEUTICS Common Stock Stock (PSTV) from India?
Indian investors can start investing in PLUS THERAPEUTICS Common Stock (PSTV) shares with as little as ₹94.665 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.65 in PLUS THERAPEUTICS Common Stock stock (as per the Rupee-Dollar exchange rate as on ).
Based on PLUS THERAPEUTICS Common Stock share’s latest price of $3.96 as on June 25, 2026 at 8:46 am IST, you will get 2.5253 shares of PLUS THERAPEUTICS Common Stock. Learn more about
fractional shares .
What are the returns that PLUS THERAPEUTICS Common Stock has given to Indian investors in the last 5 years?
PLUS THERAPEUTICS Common Stock stock has given -99.62% share price returns and 27.62% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?